PITTSBURGH, April 24th, 2014 — Gateway Analytical announced today that they will be exhibiting and presenting at the upcoming Respiratory Drug Delivery (RDD) conference in Fajardo, Puerto Rico, May 4-8. RDD is an international conference that features in-depth presentations and discussions focused on the latest development in respiratory drug delivery science, in addition to industry networking. During the conference Gateway will be promoting their unique Raman chemical imaging services that provide drug developers with truly chemically specific particle characterization. This chemical specificity is the key to understanding the extend of agglomerations in orally inhaled drug products (OINDPs), which is critical for safety, stability and FDA submission.
PITTSBURGH, March, 11th, 2014 — Gateway Analytical announced today that they have collaborated with researchers from the Division of Pharmaceutical Analysis at the Food and Drug Administration’s Drug Evaluation and Research Center (FDA/CDER) to present new findings on temperature-mediated agglomeration assessment in Orally Inhaled and Nasal Drug Products (OINDP’s) at the upcoming Respiratory Drug Delivery (RDD) conference in Fajardo, Puerto Rico, May 4-8, 2014.
Henry Ford once said, “Quality means doing it right when no one is looking.” Here at Gateway Analytical we take great pride in the quality of the work we do, knowing that we provide our customers with a top notch product. The quality of the work is directly related to the commitment to overall quality, starting at the top of our organization.
Gateway Analytical has teamed up with researchers from the Division of Pharmaceutical Analysis at FDA/CDER to present new findings on temperature-mediated agglomeration assessment in Orally Inhaled and Nasal Drug Products. This study was performed to address aqueous nasal spray suspensions stability during long-term shipping/storage. During the study, suspension formulations were subjected to temperatures that may possibly be reached inside shipping containers during hottest and coldest months in St. Louis, MO.
PITTSBURGH, January, 21 2014 — Gateway Analytical announced today that they have acquired the RapID SPE-ls raman.ID + metal.ID® system, the latest technology in automated particle identification. This acquisition enhances existing analytical service offerings to the pharmaceutical and materials science industries, and makes Gateway one of only two analytical service laboratories in the United States that can offer this advanced technology.
Presented at: Drug Delivery to the Lung 24, 2013
Authors: O Olkhovyk1, R Price 2 and J Shur 2
1. Gateway Analytical, 5316 William Flynn Highway, Gibsonia, PA 15044
2. University of Bath, Bath, BA2 7AY, UK
Release Date: Thurs., Dec 12, 2013
Original Event Date: Tuesday, December 17, 2013
Duration: 60 minutes
Presenters: David Exline, Senior Vice President & Antonio Scatena, Laboratory Manager at Gateway Analytical
Host: Shawn Wilhelm, Marketing Coordinator at Gateway Analytical
On November 20th, Antonio Scatena, Laborator Manager and Cara Plese, Scientist at Gateway Analytical hosted a webinar designed for scientists working in the pharmaceutical industry. During this webinar, they discussed the advantages of using Raman analysis in conjunction with other analytical techniques, such as microscopy, SEM/EDS and FTIR in investigations to identify unknown materials. They discussed the sample types that are best suited for Raman analysis and tips on how to discover the best parameters to use for you investigation. They also discussed how Raman Analysis can be used to analyze inorganic materials, such as metal oxides, pigments and minerals which would typically not yield results with FTIR analysis.
Recently, the American Association of Pharmaceutical Scientists (AAPS) released a post on their blog authored by Binodh DeSilva, Executive Director of Immunochemistry and Biomarker Development and Mark E. Arnold, Ph.D., Executive Director of the Bioanalytical Sciences and Selective Integration Department at Bristol Myer Squibb on the FDA and industry discussing crucial draft bioanalytical method validation guidance. Here is an excerpt from the post:
In the day and age of emails, texts and social media; communication has become an ever present topic of discussion. After all, why would Led Zepplin take the time to sing about communication (and its breakdown…) if it wasn’t such a large part of our lives? But even with all the new technology we have at our fingertips today, communication has always been something that professionals are expected to master and execute with ease. This is an especially important skill set when considering quality, as communication is imperative to not only the maintenance of quality systems but also their proliferation.